GIST Cancer UK News
Please see the latest news, research and findings below...
Phase 2 Trial
Combination treatment with avelumab and regorafenib has shown activity in patients with relapsed/refractory gastrointestinal stromal tumors (GIST), according to research presented at the ESMO Congress 2023.
Continue reading →Autumn Newsletter
The Autumn Newsletter has arrived with updates on a range of GIST-related matters. GIST Cancer UK October Newsletter
Continue reading →Leeds Sessions
Videos of the sessions at the October 2023 Patient Carer meeting held in Leeds are now available on the Patient Meetings 2023 section of this site.
Continue reading →Ripretinib vs Sunitinib
The outcome of the recent Intrigue study which compared the effectiveness and side effects associated with these drugs can be found here
Continue reading →Managing side effects
The Life Raft. Group (the US equivalent of GIST Cancer UK) hold a series of online events that may be of interest to patients and carers in the UK. The next one is on September 18th and is entitled: Managing the side-effects of GIST therapies.
Continue reading →Donations
The Board of Trustees continue to look at how the charity operates in order to keep costs low and bureaucracy to a minimum. Following a review of our financial structure, we are reducing the number of bank accounts we have and instead starting to utilise facilities that attract bank interest. To facilitate this, we ask […]
Continue reading →Scottish Patient/Carer Meeting
The annual Scottish patient meeting will take place on Friday, 1st December 2023 at the Cosla Conference Centre, Verity House, 19 Haymarket Yards, Edinburgh EJ12 5BH. To book a place please email meetings@gistcancer.org.uk
Continue reading →May 2023 Newsletter
The May edition of our new newsletter is now available and can be downloaded here. GIST Cancer UK May Newsletter
Continue reading →Presentations from the London meeting
Video recordings from the recent London Patient/Carer event are now available under the ‘Patient Meetings‘ section of this site.
Continue reading →Generic Imatinib poster
At the recent BSG Conference, Drs Bulusu and Jennifer Harrington presented findings from an initial exploration of the effectiveness of different generic versions of imatinib,
Continue reading →